Details for Patent: 10,596,155
✉ Email this page to a colleague
Which drugs does patent 10,596,155 protect, and when does it expire?
Patent 10,596,155 protects NUVESSA and is included in one NDA.
This patent has fourteen patent family members in eight countries.
Summary for Patent: 10,596,155
Title: | Aqueous-based metronidazole gel formulations |
Abstract: | The present disclosure provides mucoadhesive aqueous-based gel formulations of metronidazole useful for a variety of purposes including intravaginal application as a therapeutic approach towards the treatment of individuals suffering from and/or diagnosed with bacterial vaginosis. |
Inventor(s): | Nordsiek; Michael T. (Wayne, PA), Balaji; Kodumudi S. (Landsdale, PA) |
Assignee: | CHEMO RESEARCH, S.L. (Madrid, ES) |
Application Number: | 16/247,497 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,596,155
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,596,155
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2012275292 | ⤷ Sign Up | |||
Australia | 2016200825 | ⤷ Sign Up | |||
Brazil | 112013033759 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |